JAMA+ Trials Editor’s Choice for Clinical Trial of 2025 in JAMA Dermatology

Дата публикации: 01-09-2026 00:00:00

The launch of the JAMA Network’s JAMA+ Trials channel presents a special opportunity to highlight notable clinical trials published in JAMA Dermatology. We are pleased to recognize “Emollients to Prevent Pediatric Eczema: a Randomized Clinical Trial” as our Editor’s Choice for Clinical Trial of 2025. This trial found that daily moisturizer use beginning before age 9 weeks may prevent the development of atopic dermatitis in children.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	JAMA Dermatology	0	5.68	01-09-2026
2	Patient Engagement With Dermatology Notes in the Electronic Patient Portal	0	9.2	01-09-2026
3	High-Dose Oral Vitamin D for Toxic Effects of the Skin Associated With Chemotherapy and Radiation	0	8.17	01-09-2026
4	Melanoma Prevention Among Children of Melanoma Survivors	0	8.06	07-10-2026
5	EADV: Autonomous AI Can Increase Clinical Capacity for Dermatologists	0	9.51	06-10-2026
6	Galderma’s Nemluvio shows sustained improvements in moderate-to-severe atopic dermatitis	0	21.96	02-10-2026
7	Generalized Linear Keratotic Papules in a Man in His 30s	0	6.38	30-09-2026
8	Enfortumab Vedotin−Induced Cutaneous Toxic Effects and Survival in Urothelial Carcinoma	0	6.29	01-09-2026
9	EEMC: Intranasal Sufentanil-Ketamine Appears Safe, Effective for Pediatric Acute Pain	0	13.47	06-10-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 6.57. Источник: archderm.jamanetwork.com.